Core Insights - Corbion reported strong financial results for the year ending December 31, 2025, with significant growth in sales and adjusted EBITDA, reflecting the company's effective strategies in sustainable food ingredients [1][6]. Financial Performance - Organic sales growth for 2025 was +2.2%, with Q4 showing a stronger growth of +5.4% [2]. - Total sales reached €1,267.4 million for the year, with Q4 sales at €310.2 million [2][4]. - Adjusted EBITDA for the year was €204.3 million, representing a +26.7% organic growth, with Q4 adjusted EBITDA at €48.0 million [2][4]. - Operating profit increased to €116.5 million, reflecting an organic increase of +66.1% [2][4]. - Earnings per share (EPS) rose by +63.3% to €1.29 [2]. Dividend Proposal - The company proposed a dividend distribution of €1.00 per share, which includes a regular dividend of €0.64 and a special dividend of €0.36, highlighting its commitment to shareholder returns [2][6]. Segment Performance - In the Functional Ingredients & Solutions segment, positive volume/mix contributed to sales growth, with adjusted EBITDA margins improving by +230 basis points due to cost reductions and specialty product development [7]. - The Health & Nutrition segment experienced high-single-digit percent volume/mix growth, with Q4 showing particularly strong growth of +40%. The segment maintained a full-year adjusted EBITDA margin of 32.5% [8]. Future Outlook - For FY 2026, the company anticipates organic sales growth of +3-6% and an adjusted EBITDA margin of approximately 17%, with free cash flow expected to be around €85-90 million [5].

Financial Performance - Prosafe SE reported Q4 2025 EBITDA of USD 21.1 million, significantly up from USD 8.4 million in Q4 2024 [1][6] - Full-year 2025 EBITDA reached USD 40.0 million, an increase from USD 27.2 million in 2024, and at the high end of the guided range for the year [2][5] - Revenues for Q4 2025 were USD 70.9 million, compared to USD 37.0 million in the same quarter last year [6] Operational Highlights - The company achieved 100% fleet utilization in Q4 2025, with all five units under contract [6] - Safe Boreas commenced operations in Australia ahead of schedule, starting full day rate from December 15, 2025 [1][6] - The backlog reached USD 428 million, including options and excluding the letter of intent for Safe Caledonia [6] Market Outlook - Prosafe is positioned for continued earnings growth in 2026, with full-year EBITDA expected to be in the range of USD 45-55 million [2][5] - The company is experiencing strong demand in the global offshore accommodation market, particularly in Brazil and Africa [6] - All high-end vessels are contracted through 2026 and into 2027, reflecting significant commercial progress [5][6]

Core Insights - Syensqo reported a full year free cash flow of €356 million, exceeding prior expectations, and a pro forma underlying EBITDA of €1.21 billion with resilient margin performance [1][5][19] - The company experienced a 4% year-on-year net sales growth in Composite Materials, supported by a strong fourth quarter [1][5][19] Q4 2025 Highlights - Net sales for Q4 2025 were €1.42 billion, impacted by year-on-year foreign exchange movements (-6%) and lower volumes (-5%), while pricing remained stable [5][39] - Gross profit decreased by 18% year-on-year to €397 million, resulting in a gross margin of 28% [5][39] - Underlying EBITDA for Q4 was €238 million, a 20.2% decrease year-on-year, primarily due to lower performance in Specialty Polymers and Technology Solutions [5][39] - The underlying EBITDA margin contracted to 16.8%, down 190 basis points year-on-year [5][39] - Operating cash flow was €252 million, and free cash flow was €136 million, supported by working capital inflows [5][39] FY 2025 Highlights - Full year net sales totaled €6.14 billion, affected by foreign exchange movements (-3%) and lower volumes (-3%), with stable pricing [5][26] - Gross profit for the year was €1,901 million, down 14% year-on-year, leading to a gross margin of 31% [5][26] - Underlying EBITDA for the full year was €1,210 million, a 12% decrease year-on-year, mainly due to lower contributions from Specialty Polymers and Novecare [5][26] - The underlying EBITDA margin for the year was 20%, a decline of 210 basis points year-on-year [5][26] - The underlying profit attributable to Syensqo shareholders was €381 million [5][26] Shareholder Returns and Strategic Moves - The company repurchased approximately 1,687,000 shares, amounting to around €116 million, and proposed a dividend of €1.62 for 2025 [5][26] - The divestment of the Oil & Gas business unit was completed in January 2026 for an enterprise value of €135 million, advancing the company's specialty strategy [5][26] 2026 Outlook - The company anticipates continued macroeconomic and demand uncertainty across most end markets in 2026 [9][28] - Expected low single-digit volume growth in 2026, with Composite Materials leading the improvement due to strong demand in civil aerospace [10][48] - Specialty Polymers are expected to see modest volume growth, offset by lower volumes in Consumer Electronics [11][30] - The gross margin across core business units is expected to remain stable compared to 2025 [14][52] - The company is on track to deliver over €200 million in cost savings by the end of 2026 [15][53]

Sales revenue of Tallinna Sadam in 2025 was 119 million euros. Adjusted EBITDA was close to 57 million euros and profit more than 22 million euros. Comparing to the preceding year sales revenue decreased slightly by –0.8% but adjusted EBITDA increased by +6% and profit by +17%. Sales revenue in the fourth quarter was more than 29 million euros, adjusted EBITDA was 11 million euros and profit 3.6 million euros. Comparing to the same period last year sales revenue increased by +1.3%, adjusted EBITDA decreased ...

Strong 2025 performance with renewedcommercial momentum at year-end Revenue up +10.3% in constant currencies, led by +14.4% growth in constant currencies of Planisware’s SaaS ModelCommercial momentum improving and strong bookings with new logos at year-endAdjusted EBITDA margin* up +220bps to 37.4% of revenue reflecting operational discipline and scalabilityProfit for the period up +17.0% year-on-year to € 50.0 million or € 0.71 earnings per shareStrong cash generation with adjusted FCF* reaching € 59.3 mil ...

Highlights Record results with Group turnover at 4.2 billion euros compared to 4.1 billion euros a year agoEBITDA at 931 million euros from 764 million euros a year ago, an increase of 22%, and reaching 22.4% of turnover, up from 18.6% for 2024Net profit reaching 346 million euros, compared to 288 million euros a year ago, an increase of 20%Proposed gross dividend of 4.5 euros per share, compared to 3.8 euros per share a year ago Order book stood at 7.6 billion euros at the end of the year, above both mi ...

On February 25, 2026, the fund’s subsidiary EfTEN Ermi OÜ and Tartu Südamekodu OÜ reached an agreement on the expansion of the elderly care home located at Ermi tn 13, Tila village, Tartu municipality, Tartu County. As a result, 72 additional beds will be added. The “Tartu Südamekodu” elderly care home, developed through the parties’ previous cooperation, has been providing services to clients since August 2024 and currently comprises 180 beds. By the end of last year, the facility had reached full occupan ...

Partnership with leading nuclear medicine specialist enables advancing pipeline of wholly-owned Radio-DARPin therapeutics for imaging and therapeutic radio-isotopes, including Actinium-225 (225Ac)ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced it has en ...

2025 Full year results Resilient results and strong cash flow supported by cost management and restructuring FCF1 of €314m n Proposed dividend of €1.95 n Ongoing €200m share buyback Bekaert delivered a resilient performance in 2025. The year was marked by shifts in global trade policies which created uncertainty and undermined demand. In addition, slower growth in the hydrogen end market required adjustment to bring footprint in line with demand outlook. At the same time, Bekaert has translated robust deman ...

PRESS RELEASE – FEBRUARY 26, 2026 2025 Full-Year Results In 2025, Wendel accelerated the transformation of its business model: €1591 million of proforma FRE generated by Wendel Investment ManagersStrengthened operational profile of Wendel Principal Investments Strong progress in the execution of the 2030 strategic roadmap announced in December 2025: €1.65 billion of disposals announced to date More than €5002 million to be returned to shareholders in 2026 Fully diluted3 NAV per share of €164.2 as of De ...